An explainable deep learning framework for characterizing and interpreting human brain states.

Deep learning approaches have been widely adopted in the medical image analysis field. However, a most of existing deep learning approaches focus on achieving promising performances such as classification, detection, and segmentation, and much less effort is devoted to the explanation of the designed models. Similarly, in the brain imaging field, many deep learning approaches have been designed and applied to characterize and predict human brain states. However, these models lack interpretation. In response, we propose a novel domain knowledge informed self-attention graph pooling-based (SAGPool) graph convolutional neural network to study human brain states. Specifically, the dense individualized and common connectivity-based cortical landmarks system (DICCCOL, structural brain connectivity profiles) and holistic atlases of functional networks and interactions system (HAFNI, functional brain connectivity profiles) are integrated with the SAGPool model to better characterize and interpret the brain states. Extensive experiments are designed and carried out on the large-scale human connectome project (HCP) Q1 and S1200 dataset. Promising brain state classification performances are observed (e.g., an average of 93.7% for seven-task classification and 100% for binary classification). In addition, the importance of the brain regions, which contributes most to the accurate classification, is successfully quantified and visualized. A thorough neuroscientific interpretation suggests that these extracted brain regions and their importance calculated from self-attention graph pooling layer offer substantial explainability.

SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression.

Genome-wide association studies (GWAS) have identified numerous genetic variants that are associated with lung cancer risk, but the biological mechanisms underlying these associations remain largely unknown. Here we investigated the functional relevance of a genetic region in 6q22.2 which was identified to be associated with lung cancer risk in our previous GWAS. We performed linkage disequilibrium (LD) analysis and bioinformatic prediction to screen functional SNPs linked to a tagSNP in 6q22.2 loci, followed by two case-control studies and a meta-analysis with 4403 cases and 5336 controls to identify if these functional SNPs were associated with lung cancer risk. A novel SNP rs17079281 in the DCBLD1 promoter was identified to be associated with lung cancer risk in Chinese populations. Compared with those with C allele, patients with T allele had lower risk of adenocarcinoma (adjusted OR = 0.86; 95% CI: 0.80-0.92), but not squamous cell carcinoma (adjusted OR = 0.99; 95% CI: 0.91-1.10), and patients with the C/T or T/T genotype had lower levels of DCBLD1 expression than those with C/C genotype in lung adenocarcinoma tissues. We performed functional assays to characterize its biological relevance. The results showed that the T allele of rs17079281 had higher binding affinity to transcription factor YY1 than the C allele, which suppressed DCBLD1 expression. DCBLD1 behaved like an oncogene, promoting tumor growth by influencing cell cycle progression. These findings suggest that the functional variant rs17079281C>T decreased lung adenocarcinoma risk by creating an YY1-binding site to suppress DCBLD1 expression, which may serve as a biomarker for assessing lung cancer susceptibility.